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 Summary statement 
We have created new C9orf72 linked motor neuron disease models through viral mediated 
expression of GGGGCC repeat expansions in mice. 
 
Abstract 
Intronic GGGGCC repeat expansions in C9orf72 are the most common genetic cause of 
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Two major 
pathologies stemming from the hexanucleotide RNA expansions (HREs) have been identified 
in postmortem tissue: intracellular RNA foci and repeat-associated non-ATG dependent (RAN) 
dipeptides, though it is unclear how these and other hallmarks of disease contribute to the 
pathophysiology of neuronal injury. Here we generated two novel lines of mice that 
overexpress either 10 pure or 102 interrupted G4C2 repeats mediated by adeno-associated virus 
(AAV) and characterized relevant pathology and disease-related behavioral phenotypes. 
Similar levels of intracellular RNA foci developed in both lines of mice, but only mice 
expressing 102 repeats generated c9-RAN pathology, neuromuscular junction (NMJ) 
abnormalities, dispersal of the hippocampal CA1, enhanced apoptosis, and deficits in gait and 
cognition. Neither line of mice, however, showed extensive TAR DNA-binding protein 43 
(TDP-43) pathology or neurodegeneration. Our data suggests that RNA foci pathology is not a 
good predictor of c9-RAN dipeptide formation, and that RAN dipeptides and NMJ dysfunction 
are drivers of c9-disease pathogenesis. These AAV-mediated models of C9orf72 ALS/FTD 
will be useful tools for studying disease pathophysiology and developing new therapeutic 
approaches. 
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Introduction 
Hexanucleotide repeat expansions (HREs) in C9orf72 are regarded as the most common 
genetic cause of the progressive neurodegenerative diseases, amyotrophic lateral sclerosis 
(ALS) and frontotemporal dementia (FTD). ALS primarily affects motor neurons and leads to 
progressive failure of the neuromuscular system with muscle wasting and paralysis, while 
frontotemporal dementia (FTD) is caused by the degeneration of neurons in the frontal and 
temporal lobes leading to cognitive deficits. G4C2 repeat expansions in the first intron of 
C9orf72 are present in up to 40% of familial ALS and 25 % of familial FTD patients, and are 
also present in 5-20% of sporadic ALS patients (DeJesus-Hernandez et al., 2011, Renton et al., 
2011, Majounie et al., 2012, Renton et al., 2014). Normal healthy C9orf72 alleles contain 
between 2-30 repeats, while disease-associated alleles vary in size and can exceed several 
thousand HREs (DeJesus-Hernandez et al., 2011, Renton et al., 2011).  Three different 
pathological alterations providing clues to the etiology of C9orf72-related disease can be found 
in post-mortem tissue from patients with HREs: first, a reduction in all three mRNA transcripts 
generated from C9orf72, suggesting disease may arise by a loss-of-function mechanism 
(DeJesus-Hernandez et al., 2011, Belzil et al., 2013, Donnelly et al., 2013); second, formation 
of intracellular foci by aggregation of RNA expansions; and third, dipeptide repeat proteins 
(DPRs) which are generated from long expansions via repeat-associated non ATG-dependent 
(RAN) translation (Cooper-Knock et al., 2014, Schludi et al., 2015).   
 
Recent studies suggest that G4C2 expansions and DPRs may induce cell toxicity by 
sequestration of RNA binding proteins (Cooper-Knock et al., 2014, Lee et al., 2016) and 
disruption of nucleocytoplasmic transport (Zhang et al., 2015, Freibaum et al., 2015). Models 
designed to mimic either C9orf72 haploinsufficiency or toxic gain of function have been 
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 developed to identify the combination of factors inducing disease relevant pathology. While 
C9orf72 knockout mice display motor and cognitive deficits along with heightened 
neuroinflammation, these mice do not exhibit any significant neuronal pathology, suggesting 
that a simple loss-of-function mechanism is unlikely to be the sole cause of C9orf72-linked 
neurodegeneration (Koppers et al., 2015, O'Rourke et al., 2016). Four different toxic gain-of-
function mouse models developed through expression of patient derived C9orf72 containing 
hundreds of HREs consistently displayed intracellular RNA foci and DPRs in the CNS, though 
they differed in the generation of ALS/FTD disease phenotypes (Jiang et al., 2016, Liu et al., 
2016, O'Rourke et al., 2015, Peters et al., 2015, Chew et al., 2015). In contrast, acute AAV-
mediated, actin-promoter-driven expression of 66 repeats in mice recapitulates ALS-like 
pathology and induces cognitive and behavioral deficits, despite lacking any flanking C9orf72 
sequence (Chew et al., 2015).  
 
Interruptions in repeat expansions are found in alleles for spinocerebellar ataxia (SCA) (Chung 
et al., 1993, Pearson et al., 1998a, Matsuura et al., 2006), Myotonic dystrophy type 1 (Musova 
et al., 2009), Friedreich ataxia (Stolle et al., 2008) and Fragile X syndromes (Eichler et al., 
1994, Pearson et al., 1998a), although the consequences of the interruptions on disease etiology 
remain unclear. Interrupting the expression of pure glycine-alanine (GA) dipeptide repeats with 
proline residues in mice prevented the formation of dense ubiquitin-positive inclusions and the 
development of behavioral phenotypes and pathological hallmarks consistent with C9orf72-
ALS/FTD (Zhang et al., 2016). An interruption in the expression of DPRs created by inserting 
stop codons between G4C2 repeats in Drosophila blocked DPR formation and 
neurodegeneration but preserved RNA foci generation demonstrating that DPRs are toxic 
(Mizielinska et al., 2014).  Here, we generated mice expressing HREs, utilizing AAV serotype 
9 (AAV9) to achieve an acute, widespread expression following cisterna magna delivery in 
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 postnatal day 1 (P1) pups. We compared mice expressing 10 HRE expansions to mice 
expressing 102 repeats interrupted at regular intervals to examine the effects of interrupted 
expansions on disease etiology. We show that both AAV-(G4C2)10  and AAV-(G4C2)102  repeats 
lead to the formation of a similar number of intranuclear RNA foci in the CNS in vivo, but only 
(G4C2)102 transgenic mice generate DPRs and p62 inclusions, have Purkinje cell apoptosis, 
exhibit neuromuscular junction pathology, and display gait and cognitive deficits.           
  
 
 
Materials and Methods 
 
Antibodies and Reagents 
Rabbit anti-AAV VP1, VP2, VP3 (1:800, #03-61084, American Res Prod, USA), rabbit anti-
NeuN (1:500, Cell Signalling (USA)- clone D3S3I), rabbit anti-GFAP (1:2000, Dako - Z0334), 
rabbit anti-TDP-43 (1:500, Proteintech - catalog #18-280-1-AP), mouse anti-TDP43-phospho 
ser409/410-1 (1:4000, Cosmo Bio – cat#:CAC-TIP-PTD-M01), mouse anti-Calbindin (1:1000, 
Sigma C9848), mouse anti-p62 lck ligand (1:1000 (WBlot), 1:250 (ICC), BD Biosciences, 
clone 3, cat#:610833), rabbit anti-α-tubulin (1:5000, Abcam, cat #4074), rabbit-cleaved-
caspase 3 (1:1000, Cell Signalling #9661), mouse anti-cleaved PARP (1:250, Cell Signalling 
#9548), mouse anti-GAPDH (1:5000, Millipore), mouse anti-poly(Glycine-Alanine (GA), 
1:500 for western blot; 1:5000 for ICC, clone 5F2 (Mackenzie et al., 2013) kindly provided by 
Dieter Edbauer)  were used at the dilutions listed above.  
  
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
  
Cell lines and culture  
HEK 293T cells were maintained in growth media (GM) consisting of Dulbecco’s modified 
Eagle’s medium (DMEM, D5796, Sigma (USA)) supplemented with 10% foetal bovine serum 
(Sigma, USA), penicillin (100U/ml), and streptomycin (100U/ml) at 37°C and 5% CO2.  
 
Generation of Repeat Expansion Constructs 
Sense (TCGAC (G4C2)10) and antisense (ACGT(G4C2)10) oligonucleotides (Sigma-Aldrich) 
with SalI/XhoI overhangs were annealed by denaturing at 95ºC for 5 min and cooling at 
0.5ºC/min to 25ºC. The dsDNA (G4C2)10 was ligated into SalI and XhoI digested pcDNA6.2-
GW/EmGFP-miR (Invitrogen) to generate pcDNA6.2-GW-(G4C2)10. Further (G4C2)n repeats 
where n varied between 10-17 repeats were subcloned into the XhoI site to generate the longer 
pcDNA6.2-(G4C2)102 construct. The (G4C2)10 and (G4C2)102 constructs were subsequently sub-
cloned into a pAV2-CMV (cytomegalovirus) plasmid and authenticity was confirmed by 
sequencing. Transformations of plasmids containing the (G4C2)n repeat constructs were 
performed using recombination-deficient β-10 E.coli (NEB) to minimise any rearrangements.  
 
Large scale scAAV9 production 
Sixty 15 cm plates containing HEK293 cells at 80% confluence were transfected using 
polyethylenimine (MW ~ 25K) with a mixture of three plasmids required to generate an 
infectious scAAV9 viral particle: (1) A plasmid providing helper genes isolated from 
adenovirus that enhance viral infectivity (pHelper); (2) An ITR-containing plasmid carrying 
the gene of interest (pAV2-CMV-(G4C2)n; we used the pAV2-CMV-GFP consisting of two 
ITRs in a truncated genome that resulted in a self-complementary AAV9 (scAAV9), as 
described by others (McCarty et al., 2001)); (3) A plasmid that carries the AAV Rep-Cap 
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 proteins (pAAV2/9). Each 15cm plate was transfected with a total of 40µg of DNA comprised 
of a 2:1:1 molar ratio of pHelper: pAV2-CMV-(G4C2)n: pAAV2/9. Four days after transfection, 
the AAV enriched media was collected, incubated at 37°C for 2 hours with 3,750 units of 
benzonase-nuclease (Sigma, USA), filtered through a 0.22 µm filter, and concentrated to a 
volume of 1ml using Amicon spin filter units (Millipore, USA). The virus was then washed 
with 50 ml of phosphate buffered saline (PBS, pH 7.3) in the same Amicon spin filter units, 
and concentrated to a final volume of 0.5 ml. The viral sample volume was expanded to 14ml 
with PBS and separated through a discontinuous iodixanol (D1556, Sigma, USA) gradient (4ml 
of 54%, 9 ml of 40%, 9 ml of 25%, 5 ml of 15%), and centrifuged at 69,000 rpm for 1.5 hours 
at 18°C. Phenol red was added to the 54% and 25% iodixanol layers to help with identifying 
the virus enriched layer. The purified virus was found as a white layer between the 54% and 
40% iodixanol gradient and subsequently removed in 0.5ml fractions using a syringe, with 10µl 
of each fraction mixed at an equal ratio with 2X reducing sample SDS-PAGE buffer, heated to 
75°C for 20 minutes, separated on a 4-20% precast TGX mini-gel (Biorad, USA), and stained 
with Sypro-Ruby according to the manufacturer’s protocol (Life Techologies, USA). Fractions 
that showed a pure virus composed solely of the VP1, VP2 and VP3 bands were combined, 
and washed against 5 full volumes (15ml each) of PBS with an Amicon spin filter, before 
collecting in a final volume of between 300-500µl.  
 
Quantitative PCR to measure viral titres 
Viral titres were determined with the Quantifast SyBR Green PCR Kit (Qiagen, Cat 204054) 
on a BioRad CFX96 thermal cycler, following the manufacturer's instructions. The number of 
copies in three dilutions of a purified AAV9 virus (1/100, 1/1000, 1/10,000) were compared to 
a standard curve generated by serial dilutions of a linearized pAV2-CMV-(G4C2)n vector. 
Primers used to quantify viral genomes were (Poly A, Forward: 5’-ATT TTA TGT TTC AGG 
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 TTC AGG GGG AGG TG-3’), (PolyA, Reverse: 5’-GCG CAG AGA GGG AGT GGA CTA 
GT-3’).  
 
RNA Fluorescent in-situ hybridization (FISH) 
RNA FISH was performed as described previously (Cooper-Knock et al., 2014) with a few 
modifications. Briefly, a 5’ TYE-563-labelled LNA (16-mer fluorescent)-incorporated DNA 
probe was used against the sense RNA hexanucleotide repeat (Exiqon, Inc., batch number 
607323). Coronal brain sections (20 µm) directly cut onto slides were air dried, and then 
incubated in ice cold acetone for 10 minutes before washing in PBS. Slides were blocked with 
a hybridization solution [50% formamide, 2× saline sodium citrate (SSC), 100 mg/ml dextran 
sulphate, 50 mM sodium phosphate pH 7.0] for 1 h at 66°C and then incubated with 400 ng/ml 
of denatured probe in hybridization solution overnight at 66°C. After hybridization, slides were 
washed once in 2×SSC/0.1% Tween-20 at room temperature and three times in 0.1× SSC at 
65°C and counterstained with Hoechst 33342. All solutions were made with DEPC-treated 
water. 
 
Generation of AAV9-mediated mouse model 
Mice were kept in a 12-hour dark/12-hour light cycle, with free access to food and water and a 
standardized room temperature, based on the UK Home Office Code of practice for the housing 
and care of animals used in scientific Act 1986. All in vivo experiments carried out in this study 
were performed according to the Animal (Scientific Procedures) Act 1986, under the Project 
License 40/3739, and were approved by the University of Sheffield Ethical Review Sub-
Committee and the UK Animal Procedures Committee (London, UK). 
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 Viruses (4.5x1010 vg; scAAV9-CMV-(G4C2)10 or scAAV9-CMV- (G4C2)102) were injected into 
the cerebrospinal fluid (CSF) of postnatal 1 (P1) C57BL/6J wild-type mice, via the cisterna 
magna, under general anaesthesia. Pups from the same breeding pair were allocated randomly 
to the experimental groups. Viral delivery was carried out following the protocol described in 
previously (Lukashchuk et al., 2016). Briefly, pups were anaesthetized in an induction chamber 
using 5% isoflurane and oxygen at 3 L/min before placing the animal over a red 
transilluminator in the prone position. Viruses were loaded in a Hamilton syringe attached to a 
peristaltic pump and injected into the cisterna magna, using a stereotaxic apparatus, at a flow 
rate of 1 µl/min to a maximum volume of 5 µl. Anaesthesia was maintained with 2% isoflurane 
and oxygen at 0.3 L/min during the injection.  
 
Immunohistochemistry 
Twelve months after injection, animals were sacrificed under terminal anaesthesia and 
transcardially perfused using a solution of PBS-heparin followed by 4% paraformaldehyde 
(PFA) in PBS. Brain and spinal cords were harvested and further post-fixed overnight in 4% 
PFA. After fixation, tissue was washed with PBS, cryoprotected in 30% of sucrose at 4°C, 
embedded in OCT (Cell Path®), and snap frozen in liquid nitrogen. Brains and spinal cords 
were cut in 20 μm thick coronal sections on a cryostat (Leica), placed directly onto silane 
treated slides, and then air dried. Sections were incubated with gentle agitation for 2 hours at 
room temperature in blocking buffer (PBS with 5% normal goat serum, 3% BSA and 0.2% 
Triton-X-100) before incubating overnight at 4°C with the appropriate antibody diluted in PBS 
with 3% BSA. Following three washes with PBS, sections were incubated with an appropriate 
alexa fluorophore conjugated secondary antibody (1:1000; Invitrogen, CA) for 1 hour at room 
temperature, counterstained with Hoechst 33342 and mounted onto slides with Fluoromount 
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 (Sigma). For visualizing DPR pathology, slides were immersed in sodium citrate buffer (10mM 
Sodium Citrate, 0.05% Tween 20, pH 6.0) for 30 minutes at 60°C before the blocking step. We 
used a Nissl stain (0.1% Cresyl Fast Violet; BDH, Lutterworth, UK) on spinal cord sections 
for counting motor neurons, and in cerebellar brain sections for visualizing p62 expression.  
 
Neuromuscular junction (NMJ) pathology 
NMJ pathology was assessed on whole-mount immunohistochemically-labelled preparations 
of hindpaw lumbrical muscles from 1 year old mice, as described previously (Powis et al., 
2016, Wishart et al., 2014). Images were captured using a Nikon A1R confocal system 
combined with a Ti:E inverted microscope (×60 objective). Individual NMJs were assessed 
and abnormalities quantified, by eye, for evidence of neuromuscular pathology (presence of 
axonal blebbing/thinning or abnormal neurofilament accumulations in distal motor axons 
and/or motor nerve terminals). NMJ analysis was performed by investigators blinded to the 
treatment group. 
 
Quantitative Fluorescence Imaging 
To assess the effect of CG repeats on the postsynaptic receptor density (marker of synapses), 
muscle cells were labeled with a saturating dose of fluorescent BTX (5 ug/ml, ~1 hour) and 
images of NMJs were collected using IPLAB software as described previously (Akaaboune et 
al., 1999, Martinez-Pena et al., 2015). The fluorescence intensity of labeled AChR was 
analyzed with algorithms for Matlab (The Mathworks).  Background fluorescence was 
determined by manual selection of a boundary region around the each NMJ and subtracting it 
from the original image, and the mean of the total fluorescence intensity (which corresponds 
to total fluorescence of that synapse divided by the area of that given synapse) was measured 
(Turney et al., 1996, Akaaboune et al., 1999, Martinez-Pena et al., 2015).  
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Immunoblotting 
Adult mice were sacrificed using an overdose of sodium pentobarbitol, and brains were rapidly 
dissected and snap frozen with liquid nitrogen. Brains were then homogenised in RIPA buffer 
using a glass dounce homogenizer (150mM NaCl, 50mM Tris  pH8, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulphate (SDS), 1% NP-40 supplemented with 1X EDTA-
free protease inhibitor cocktail (Roche)) for 30 minutes on ice and centrifuged at 17,000 g at 
4°C for 10 minutes. Supernatant was then collected as a cytoplasmic fraction and used to 
examine p62 reactivity. To examine poly (GA) DPRs, the membrane enriched pellet was 
further solubilized in a buffer containing 1% Triton-X-100 and 0.5M NaCl in 10mM Tris-HCl 
(pH 7.4) for 45 minutes at 4°C with constant agitation and centrifuged at 17,000g at 4°C for 10 
minutes. Supernatant was collected as the triton-soluble fraction and the pellet was re-
suspended in a buffer containing 2% SDS in 10mM Tris-HCl (pH 7.4) and stored as the Triton 
insoluble fraction. Protein lysates were mixed with a 4X Laemmli buffer with 5% β-
mercaptoethanol, heated to 95°C for 5 minutes, separated with a 10% SDS-PAGE and 
transferred onto a PVDF membrane (Millipore). Membranes were blocked with either 5% BSA 
or 5% nonfat dry milk in TBS with 0.05% Tween (TBST) for 30 minutes, before incubating at 
4°C overnight with agitation with the appropriate antibody diluted in 5% BSA in TBST. 
Following three washes in TBST for 10 minutes each, membranes were incubated at room 
temperature with mild agitation with an appropriate secondary HRP antibody (Sigma Aldrich, 
1:5000) diluted in 5% BSA in TBST, washed three times with TBST for 10 minutes each, and 
developed with enhanced chemiluminescent substrate (Amersham-Pharmacia Biotech, USA).      
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Mouse Behavioural Tests 
All mouse behavioural experiments were performed with the experimenter blind to the mouse 
cohort groups. 
 
Open Field 
The open field was a 60cm x 40cm x 25cm semi-transparent plastic box with a grid of 3x5 
squares drawn on the underside of the box with black paint. Open field activity was measured 
in a room with minimal light for 10 minutes with the number of squares crossed recorded. A 
square crossing was defined as the passage of all four mouse paws over one of the boundaries 
of a square.  
 
Object Recognition 
Mice were tested for their ability to remember novel objects using a paradigm described by 
others (Leger et al., 2013). Briefly, on day 1 mice were habituated in a rectangular 60cm x 
40cm x 25cm open field for three minutes. On the second day, mice were placed in the same 
box with two identical objects, and allowed to explore until a total of 20 seconds of exploration 
between the two objects had elapsed. Exploration was defined as mice actually sniffing, biting, 
touching with paws or examining the object. On the third day, one of the objects was replaced 
with a novel object, and the time measured at each object was recorded until a total of 20 
seconds had elapsed. To make sure that the objects were interesting enough to entice mice to 
explore them, the first object was a standard red capped 75cm2 tissue culture flask (Sigma, 
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 C7231) filled with a layer of purple dye treated agarose, while the second object was a stack 
of red slide boxes taped together.    
 
Gait analysis 
To analyse the gait pattern, 6 and 12 month old mice were placed on the Catwalk XT (Noldus®, 
Netherlands), where they had to traverse a narrow chamber in the dark. Their footprints were 
automatically recorded with the Catwalk 7.1 software from Noldus®. Six runs were performed 
per animal and the three best (chosen for mice walking along the chamber path as opposed to 
repeatedly stopping) were selected for analysis. All results are expressed as the average of 3 
runs ± SEM. The following parameters were measured and defined as: 
 Stand. The time the paws spends in contact with the Catwalk surface. 
 Base of support (BOS). Distance between either the front or hind paws. 
Diagonal support. Time spent on the Catwalk surface by a front paw and its opposing       
hind paw simultaneously (Right front paw – rear hind paw). 
Three support. Time spent on the Catwalk surface by three paws at the same time to 
support animal.  
Swing. Time between two consecutive placements in which the paw is not in contact 
with the Catwalk surface. 
Swing speed. This parameter is calculated by dividing the stride length by the swing 
phase duration.  
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Hind limb splay 
Twelve month old mice were suspended by the tail and the splay defects were observed and 
scored for right and left hind-limbs by using the following scale: 0:normal splay; 1:mild defect; 
2: moderate defect; 3: strong defect; 4: paralysed as previously described (Mead et al., 2011) 
The results show the average of each group ± SEM. 
Rotarod  
Performance on the rotarod (Ugo Basile 7650) was assessed every 2 weeks, twice per day, 
beginning 2 months after injection. Mice were initially trained for 3 consecutive days before 
the first trial. The rotarod was set to accelerate from 3 to 37 rpm in 300 seconds and the 
maximum time spent on the rotarod in a single trial out of two trials tested was recorded.  
 
Statistical Analysis 
Results are shown as mean ± standard error (S.E.M.). Student's unpaired t-test with a Welch’s 
correction for two group comparisons was used to assess differences between HRE-10 and 
HRE-102 mice. For comparisons between three groups (PBS injected, HRE-10 and HRE-102 
mice), a one-way analysis of variance (ANOVA) was used with Tukey's multiple comparison 
post-hoc test when p < 0.05. For assessing the effects of age on the gait and activity in each 
mouse cohort, we used a two-way ANOVA with a Sidak’s test for multiple comparisons when 
p<0.05. For all tests, a P-value < 0.05 was taken as statistically significant, and Graphpad Prism 
6 was used for all statistical analyses. 
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 Results 
 
Injection of AAV9-(G4C2)10 and AAV9-(G4C2)102 generate intranuclear RNA foci in vivo 
In these studies, we used self-complementary AAV9, due to its enhanced CNS transduction 
efficiency compared to single stranded AAV9 (McCarty et al., 2001) and its ability to achieve 
transduction in multiple regions of the mouse brain (Lukashchuk et al., 2016).  To generate 
mice expressing HREs, we first constructed two separate AAV9 vectors containing either 10 
or 102 HREs (Figure 1A). The AAV9-(G4C2)102 (referred to as HRE-102) construct was made 
by ligating between 10-17 HREs separated by a short TCGAG linker sequence, which 
interrupts the sequence without introducing a stop codon, resulting in mixed dipeptide proteins. 
The advantages to using this approach are: firstly, the interruptions potentially stabilized the 
sequence, reducing the risk of DNA rearrangements between the flanking inverted terminal 
repeats (ITRs) of the AAV; secondly, we could test whether c9-pathological hallmarks, such 
as DPRs, p62 inclusions, and TDP-43 aggregation, still persist in the presence of interrupted 
repeat sequences.  
 
Mice expressing repeat expansions were generated by delivering AAV9-HREs to early 
postnatal (P1) mice via the cisterna magna, which resulted in widespread transduction of the 
adult mouse brain as described in our previous work (Lukashchuk et al., 2016). Twelve months 
after AAV9 delivery, mice were sacrificed and different brain and spinal cord tissue was 
analysed using RNA fluorescent in situ hybridization (FISH) to see whether intracellular RNA 
foci were present. We found that the regions with the highest number of RNA foci per area 
were the brain stem, Purkinje cell layer of the cerebellum, CA1 and hilus of the hippocampus, 
midbrain, and cortex (Figure 1B-D). RNA foci were also detected in the spinal cord, even 
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 though they were less numerous in this region (Figure 1E). The majority of RNA foci were 
intranuclear (Fig 1D-E, white arrowhead), but we also detected perinuclear foci (Figures 1F-
G, arrow) and occasionally observed cytoplasmic foci (Figure 1F, yellow arrowhead). There 
were no significant differences in the number of RNA foci between the HRE-10 mice and 
HRE-102 in any of the regions examined (Figure 1H). 
 
HRE-102 mice exhibit extensive DPR pathology, enhanced p62 expression, and dispersed 
CA1 neurons 
To test whether the AAV9-engineered mouse model develop other pathological hallmarks of 
ALS/FTD such as c9RAN protein aggregates, TDP-43 inclusions, and neuronal loss, we used 
a poly-GA antibody (Mackenzie et al., 2013) to probe for glycine-alanine rich DPRs in mouse 
brains. As shown in Figure 2, we detected either a homogenous nuclear expression (arrow) or 
an intense, discrete staining (arrowhead) within and outside of the nucleus (Figure 2A). These 
poly-GA pathologies were most widely distributed in the cerebellum and brain stem, and 
visible only in HRE-102 treated mice (poly-GA detected in 4 out of 6 mice), and absent in 
HRE-10 expressing mice (poly-GA detected in 0 out of 6 mice). Analysis of triton-insoluble 
and soluble cerebellar/brain stem lysates isolated from a different group of HRE-10 and HRE-
102 mice identified several different sized poly-GA peptides ranging from 25-63 kilodaltons 
in both triton-soluble and insoluble fractions solely in a subset of HRE-102 mice (Figure 2B). 
Additionally, the expression of p62, a marker of cargo destined for autophagic degradation 
(Bjorkoy et al., 2005, Komatsu et al., 2007) and c9RAN pathology (Mori et al., 2013a, Mori et 
al., 2013b, Schludi et al., 2015), was enhanced in the cerebellum of HRE-102 mice (Figure 
2C), and was detected in dense intracellular (arrow) and extracellular (arrowhead) aggregates 
in HRE-102 mice (Figure 2D). 
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 Next, we examined the expression of cleaved poly (ADP-ribose) polymerase (PARP) and 
cleaved caspase-3 to see whether there was evidence of cells undergoing apoptosis. We focused 
our analysis on the cerebellum, due to the heightened DPR and p62 expression we observed in 
the HRE-102 mice (Figure 2A-D) that have been correlated to cell toxicity (Lee et al., 2016, 
Lopez-Gonzalez et al., 2016, Tran et al., 2015). As shown in Figures 2E-G, we found that 
cleaved PARP in cerebellar purkinje cells (Figures 2E-F) and cleaved caspase-3 expression 
(Figure 2G) in the cerebellum were significantly increased in HRE-102 mice, indicating that 
these areas were in the early stages of cell death. Interestingly, despite the presence of RNA 
foci and c9RAN pathology, neither astrogliosis (Figure S1) nor neurodegeneration in the 
cerebellum (Figure S2C-D) were observed. This absence of repeat-length dependent 
neurodegeneration was also observed in other regions such as the cortex (Figure S2A-B), spinal 
cord (Figure S2E-F) and hippocampus (Figure 2H-I), though there was a significant dispersal 
in the CA1 (Figure 2H-I) that is characteristic of reeler mutant mice (Howell et al., 1997, 
Trommsdorff et al., 1999). Additionally, although we were able to detect infrequent TDP-43 
aggregates (Figure S3A-B) in the cerebellum, cortex, midbrain and hippocampus of HRE-10 
and HRE-102, there was no significant difference between mouse groups with respect to TDP-
43 pathology. We also did not detect any differences between the groups with respect to 
phosphorylated TDP-43 pathology (unpublished observations, JSC). In contrast to the largely 
nuclear TDP-43 pathology reported by Chew et al (2015), the majority of TDP-43 aggregates 
in both groups of AAV-HRE injected mice were cytoplasmic (Figure S3C).  
    
HRE-102 mice develop disease-related neuromuscular junction (NMJ) pathology 
In the absence of significant loss of neuronal cell bodies in the CNS in both mouse cohorts and  
since NMJ pathology is present in several different mouse models of ALS (Iguchi et al., 2013, 
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 Frey et al., 2000, Murray et al., 2010, Bennett et al., 2014), we asked whether peripheral 
neuromuscular junctions were altered in the HRE-102 expressing mice. To do this, muscles 
from twelve-month old mice were doubly labelled with an anti-neurofilament antibody to label 
nerve terminals and fluorescent bungarotoxin to label acetylcholine receptors (AChRs), and 
NMJs were imaged with a confocal microscope. A close inspection of NMJs revealed a 
significant increase in pathological NMJs in HRE-102 mice, defined as having abnormal pre-
synaptic neurofilament accumulations and/or nerve terminal blebbings (Figure 3A,B), 
indicating that the NMJ may be an early target of c9-related toxicity. It is well established that 
the density of postsynaptic AChR is significantly reduced in mouse models of motor neurons 
disease and myasthenia gravis (Losen et al., 2005, Kong et al., 2009). Here we asked whether 
the density of AChR at NMJs of HRE-102 mice is also altered. AChRs were labeled with BTX-
594 and the density of AChR at NMJs of HRE-102, HRE-10 and PBS were compared (Figure 
3C-D). The total fluorescence of AChRs (which measured fluorescence of a synapse per area 
of the synapse) was decreased by 20% in muscles expressing HRE-102 compared with NMJs 
of PBS injected mice. These results indicate that HRE-102 expression reduces the density of 
AChRs at postsynaptic sites. Collectively, HRE-102 mice exhibit a loss in NMJ integrity at 12 
months of age that is consistent with the early stages of motor neuron degeneration.  
   
HRE-102 mice have progressive gait and behavioural deficits 
To assess whether the c9RAN and NMJ pathology have any consequences on mouse 
behaviour, we analysed motor and cognitive tasks. We used a Catwalk system to examine 
different parameters measuring motor coordination and gait in ambulatory mice, and found that 
HRE-102 mice had gait abnormalities, with significantly irregular gait patterns compared to 
HRE-10 mice in the stand, base of support (BOS), diagonal support and three support 
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 parameters (Figure 4A). When we assessed the hindlimb splay in the two cohorts (HRE-10 and 
HRE-102), we found that there was a significant defect in the right hindlimb in the HRE-102 
mice (Figure 4B). These deficits did not appear to affect the exploratory activity of the mice as 
HRE-102 mice were not significantly different to HRE-10 mice in the open field at 12 months 
of age (Figure 4C). When we analyzed data between 6 and 12 months of age from several of 
the same tasks, we noted that most of the gait parameters including ones for measuring stride 
irregularities (stand, swing, and swing speed) in addition to activity in the open field showed 
significant deterioration with age in the HRE-102 mice (Figure S4A-D), demonstrating that the 
behavioural impairments in HRE-102 mice were progressive. There were, however, no 
differences between groups in the accelerating rotarod over the ten months of testing (Figure 
S4E). We next used the object recognition paradigm to determine whether the HRE-102 mice 
had any cognitive deficits which could correlate with the CA1 dispersal demonstrated in Figure 
2D. This behavioural task exploits the innate interest of mice to explore a novel object by 
forcing mice to discriminate between a novel object and an object previously explored. Both 
sets of mice explored two novel objects without any significant difference in the familiarization 
phase (Figure 4D), but only HRE-102 mice were unable to discriminate between a novel object 
and one they had previously explored, indicating the presence of a memory deficit.  
Discussion 
Current mouse models of C9orf72 ALS/FTD have supported a toxic gain of function 
mechanism by which long G4C2 hexanucleotide RNA expansions (HREs) induce the formation 
of intracellular RNA foci and RAN protein aggregates leading to toxicity and behavioural 
dysfunction. Here we used AAVs to express either pure 10 HREs or 102 HREs containing 
regularly spaced interruptions in mice, and demonstrate that while both lines of mice have 
similar numbers of RNA foci dispersed through the brain, only AAV-HRE-102 mice generate 
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 c9RAN pathology, exhibit NMJ pathology, hippocampal CA1 dispersion, early markers of 
apoptosis, and display gait and cognitive deficits.   
 
To date, four independent mouse models expressing either a full length or truncated human 
C9orf72 with hundreds of HREs have been generated along with an AAV-mediated model 
expressing a shorter (66) number of HREs. All of these mouse models have detectable RNA 
foci and c9RAN aggregates in the brain, although the minimum size necessary to induce RNA 
foci formation differs widely. Expression of a full length C9orf72 bacterial artificial 
chromosome (BAC) transgene in mice was unable to induce RNA foci formation with  36-37  
HREs (Liu et al., 2016, O'Rourke et al., 2015), and in mice expressing a truncated C9orf72, 
expression of 100 G4C2 expansions yield limited RNA foci (Jiang et al., 2016). In contrast, 
AAV mediated expression of 66 HREs with a constitutive actin promoter generated significant 
ALS/FTD pathology which was absent when only 2 HREs were expressed (Chew et al., 2015). 
We chose a higher minimum expansion length of 10 HREs to determine whether we could 
cross the minimal threshold for generating RNA foci without forming DPRs. Surprisingly, our 
mice expressing HRE-10 yield similar numbers of RNA foci in the CNS (Figure 1H) to our 
mice expressing HRE-102 despite detecting DPRs only in the HRE-102 mice. We therefore 
conclude that RNA foci density is not an accurate predictor of DPR formation.  
 
The presence of poly-GA and p62 aggregates (Figures 2A-D) in our HRE-102 mice indicates 
that the interruptions we introduced between every 10-17 GGGGCC repeats do not prevent 
DPR formation. In contrast, interrupting AAV mediated poly-GA expression in mice with 
proline residues (Zhang et al., 2016) or inserting stop codons between extended HREs 
expressed in Drosophila melanogaster (Mizielinska et al., 2014) abolish DPR formation and 
prevent other disease related pathologies and behavioral phenotypes.  Our interrupted HRE-
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 102 construct shifted the reading frame of the translated sequence without introducing a stop 
codon resulting in the formation of mixed dipeptides as opposed to single extended tracts of 
poly-GA, poly-GR, or poly-GP. We were unable to detect robust poly-GR or poly-GP 
expression in our mice, although that is more likely due to the cross-reactivity of our antibody 
to endogenous proteins in mouse tissue, as a cell culture model expressing an inducible version 
of our HRE-102 construct detected poly-GA, poly-GP and poly-GR DPRs (Stopford et al., 
2017).  
 
Interruptions in C9orf72 expansions have not been described yet, but interrupted repeat 
expansions have been frequently detected in other neurological disorders including 
spinocerebellar ataxia (SCA) (Chung et al., 1993), Fragile X syndrome (Eichler et al., 1994), 
Myotonic dystrophy type I (Musova et al., 2009) and Friedreich ataxia (Stolle et al., 2008). 
There is no consensus on the general effects of the interruptions on disease progression, 
although there is strong evidence that interruptions can stabilize DNA sequences and prevent 
the formation of slipped DNA structures in CAG and CGG repeat disorders (Eichler et al., 
1994, Pearson et al., 1998a, Pearson et al., 1998b, Menon et al., 2013). The more rapid 
development of ALS/FTD phenotypes in the uninterrupted HRE-66 mice described by Chew 
et al (2015) compared with our interrupted HRE-102 may reflect a stabilizing presence of our 
interruptions on the expansion sequence.  
 
In large GAA expansions in Friedreich ataxia, interruptions can stabilize the DNA sequence 
(Pollard et al., 2004) without necessarily having any effect on the age of onset (Stolle et al., 
2008).  In contrast, interruptions in the CTG expansions in Myotonic dystrophy type I delay 
disease onset and suppress the muscular dystrophic phenotype (Musova et al., 2009), 
disruptions in the CGG repeats of fragile X mental retardation 1 (FMR1) protect carriers from 
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 premature ovarian failure (Bodega et al., 2006), and CAT insertions between CAG expansions 
in the ataxin-1 gene prevent the development of the full SCA1 phenotype. There is also 
evidence that interruptions can lead to the presentation of new phenotypes as disruptions in the 
ATTCT repeats in SCA10 are associated with a higher incidence of seizures (Matsuura et al., 
2006) and CAG repeats that normally cause SCA2 can lead to parkinsonism when CAA triplets 
interrupt  the CAG expansion (Charles et al., 2007).  As a result, it is difficult to draw 
conclusions to the effects of the interruptions on disease progression in our AAV-HRE-102 
mice, although it is notable that these mice develop some of the pathologies and behavioral 
phenotypes consistent with ALS/FTD suggesting that it is less likely that the interruptions led 
to a novel phenotype. It also seems unlikely that the interruptions in our HRE-102 mice disrupt 
protein aggregation like the mice described by Zhang et al (2016) which harbor proline 
interruptions between DPRs, as we detected clear poly-GA and p62 depositions in the tissue 
(Figure 2A-D).  
 
We did not observe extensive TDP-43 pathology in either the HRE-10 or HRE-102 mice and 
the majority of TDP-43 depositions were cytoplasmic (Figure S3) which contrasts with the 
nuclear TDP-43 pathology in the HRE-66 mice described by Chew et al (2015). The relative 
paucity of TDP-43 aggregates in the nucleus of our HRE-102 mice may be due to the 
interruptions disrupting the G-quadruplexes formed by pure G4C2 repeats and preventing the 
reported association between the G-quadruplexes and mRNA export proteins SRSF1 (Reddy 
et al., 2013, Zamiri et al., 2014) and hnRNPs (Conlon et al., 2016, Haeusler et al., 2014, Zamiri 
et al., 2014).  We can also not rule out the possibility that an uninterrupted RNA sequence 
influences TDP-43 deposition due to increased toxicity. Future investigations on the effects of 
interruptions on G-quadruplexes and TDP-43 export will be necessary to clarify this.   
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 As progressive deficits in spatial learning and memory and have been reported in C9orf72 BAC 
transgenic mice expressing 450 repeats (Jiang et al., 2016), we carefully examined 
hippocampal pathology in the AAV-mediated mouse models since the HRE-102 mice failed to 
discriminate between familiar and novel objects, demonstrating the presence of a cognitive 
deficit (Figure 4D). Previously, DPRs in the hippocampal CA1 of patients with C9-repeats 
have been reported (Pletnikova et al., 2014), but while we were unable to detect DPRs 
aggregates in the hippocampus, we did observe a dispersal of the CA1 (Figure 2H-I) in the 
HRE-102 mice that was reminiscent of the aberrant neuronal migration phenotype of 
Reeler/Disabled-1 mouse mutants that occurs during early development (Trommsdorff et al., 
1999, Howell et al., 1997). Interestingly knockdown of Reelin, the glycoprotein absent in 
Reeler mutant mice, impairs rats in the object recognition task, while Reelin overexpression 
can rescue deficits in the object recognition task in mouse models of Alzheimer's disease 
(Brosda et al., 2011, Pujadas et al., 2014). Further analysis will be necessary to determine 
whether any link between Reelin and C9orf72 exists.    
 
In summary, these data support a repeat-expansion length dependent gain of toxicity, with 
c9RAN formation being the likely driver of pathogenesis as the gait, motor and cognitive 
deficits precede any major TDP-43 pathology. AAV mediated expression of 102 GGGGCC 
repeats in mice leads to significant disease related pathology despite the presence of 
interruptions leading to a mixture of translated DPRs. Our model provides an interesting 
comparison to similar AAV-mediated models expressing pure repeat expansions, and may help 
uncouple the relationship between DPR formation and disease pathophysiology.  
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 Figures 
 
 
 
Figure 1. AAV9-HREs can generate RNA foci in the mouse CNS. (A) Two different HREs 
were designed and subcloned into AAV9 vectors with the (G4C2)102 expansions constructed by 
a mixture of (G4C2)10-17 oligonucleotides with an intervening linker sequence. (B-G) RNA 
fluorescent in situ hybridization was used to detect RNA foci, which were abundant in the (B) 
hippocampus (HC), (C) cortex (CTX), (D) cerebellum (CB) and sparse in the (E) spinal cord 
(SC, *motor neuron). The majority of the foci were intranuclear (D-E, white arrowhead), 
although cytoplasmic (F, yellow arrowhead) and juxtanuclear foci (F-G, arrows) were detected. 
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 (H) There were no significant differences in the number of foci detected per mm2 in either the 
HC, CTX, or CB between HRE-10 and HRE-102 mice as assessed using an unpaired two-tailed 
Student’s t-test for each region. Scale bar is 10µm. Nuclei counterstained with Hoechst 33342 
and shown as a blue stain. 
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Figure 2. Dipeptide protein repeat (DPR) pathology, hippocampal CA1 dispersal, and 
upregulation of cell death markers are observed in HRE-102 mice. (A) Cytoplasmic and 
nuclear DPRs adopt several morphologies in a subset of HRE-102 mice using a poly-(GA) 
antibody in cerebellar tissue. (B) Immunoblots of cerebellar lysates show that both triton 
soluble and triton insoluble proteins contain GA-rich DPRs in HRE-102 mice, and were never 
observed in HRE-10 mice. (C) HRE-102 mice show an increased p62 expression compared to 
HRE-10 mice in cerebellar tissue; arrowhead shows 60 kD isoform that was consistently absent 
in HRE-10 brains. (D) p62 inclusions in the cerebellum are evident in both the nucleus (white 
arrow) and cytoplasm (yellow arrowhead) of HRE-102 mice, and are absent in HRE-10 mice. 
(E-F) A significant number of Purkinje cells in the cerebellum of HRE-102 mice show signs 
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 of early apoptosis reflected by cleaved PARP immunoreactivity (n=4 for both, p=0.046). (G) 
Enhanced cleaved-caspase-3 expression is observed in cerebellar lysates from HRE-102 mice. 
(H-I) There were no differences in the number of neurons as determined by NeuN staining in 
the dentate gyrus (DG, HRE-10 (n=4), HRE-100 (n=6); p=0.66) or CA3 (HRE-10 (n=4), HRE-
100 (n=6); p=0.69) in the hippocampus between HRE-10 and HRE-102, but there was a 
significant dispersal of CA1 neurons in HRE-102 mice (HRE-10 (n=4), HRE-100 (n=6); 
p=0.046). Nuclei in (H) counterstained with Hoechst 33342 and stained blue. All comparisons 
were made with an unpaired two-tailed Student's t-test with Welch’s correction; mean ± SEM. 
Scale bar: (A): 10 µm, (D): 25 µm, (E): 10 µm, (G): 10 µm 
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Figure 3. Neuromuscular junction (NMJ) defects are present in the HRE-102 mice. (A-B) 
Abnormal neurofilament accumulation and nerve terminal blebbings (arrows) were prominent 
in HRE-102 mice (PBS:n=3, HRE-10:n=4, HRE-102:n=4; n=individual muscles per genotype; 
(F(2,8)=6.47, *p=0.02, post-hoc Tukey: HRE-10 vs PBS (p=0.19); HRE-10 vs HRE-102 
(p=0.23); HRE-102 vs PBS (p=0.02)); scale bar 30 µm. (C-D) HRE-102 mice have a significant 
decrease in acetylcholine receptor density compared to PBS injected controls (F(2,7)=10.79, 
**p=0.007, post-hoc Tukey: HRE-10 vs PBS (p=0.16); HRE-10 vs HRE-102 (p=0.056); HRE-
102 vs PBS (p=0.006)).  The fluorescence intensity (total fluorescence of that synapse divided 
by the area of that given synapse) of a saturating dose of α-bungarotoxin-alexa fluor 594 was 
measured and normalized to PBS controls. All comparisons were made with a one-way 
ANOVA and post-hoc Tukey for comparisons between groups; mean ± SEM. 
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Figure 4. Gait and cognitive deficits observed in HRE-102 mice are absent in HRE-10 
mice in 12 month old mice. (A) Gait abnormalities such as the front and hind stand index, the 
hind base of support (BOS), the diagonal support and the three-legged support were observed 
using a Catwalk system in HRE-102 mice (HRE-10 (n=11), HRE-100 (n=13) for each; front 
stand:*p=0.04, hind stand:*p=0.04; front BOS:p=0.19, hind BOS:*p=0.02; diagonal 
support:*p=0.01, three-legged support:**p=0.006). (B)  HRE-102 mice (n=13) had a moderate 
splay in the right (*p=0.04) but not left (p=0.59) hindlimb compared to HRE-10 mice (n=11). 
(C) There were no significant differences in activity (p=0.15) between HRE-10 (n=11) and 
HRE-102 (n=13) in the open field. (D) An object recognition test identified a cognitive deficit 
in HRE-102 mice (n=13) as they failed to discriminate in the testing phase (HRE-102: 
familiarization phase: p=0.43, testing phase: p=0.09) between a novel object and an object 
previously explored in the familiarization phase unlike HRE-10 mice (n=11, familiarization 
phase:p=0.57, testing phase:*p=0.02). All comparisons were made with an unpaired two-tailed 
Student's t-test with Welch’s correction; mean ± SEM.  
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Figure S1. No differences in astrogliosis between HRE-10 and HRE-102 mice. GFAP immunoreactivity in 
twelve-month cerebellar tissue was similar between HRE-10 and HRE-102 mice (n=3 for each; p=0.79, unpaired 
two-tailed Student's t-test; mean ± SEM).  
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Figure S2. No evidence of loss of neuronal cell bodies in the cortex or cerebellum of HRE-102 mice. 
(A) NeuN immunoreactivity in the cortex in twelve-month cortical tissue was not significantly different 
(B) between repeat expansion mice (n=5 for each; p=0.15, unpaired two-tailed Student's t-test with Welch’s 
correction; mean ± SEM).  (C) Calbindin immunoreactivity, used to label Purkinje cells in the cerebellum, was not 
significantly different (D) between HRE-10 and HRE-102 mice (n=5 for each; p=0.37, unpaired two-tailed Student's 
t-test with Welch’s correction; mean ± SEM). (E) Nissl staining of spinal cord sections show that there are no significant 
differences (F) between HRE-10 and HRE-102 in the number of motor neurons in the spinal cord (n=3 for each; 
p=0.87, unpaired two-tailed Student's t-test with Welch’s correction; mean ± SEM). Scale bar for (A): 10µm, 
(C): 20µm, (E): 20 µm.
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Figure S3. No differences in presence of TDP-43 aggregates between HRE-10 and HRE-102 mice. (A) Infrequent 
TDP-43 aggregates were identified in the nucleus (arrowhead) and cytoplasm (arrow) of brain tissue in (B) multiple 
regions, though there were no significant differences detected between the HRE-10 and HRE-102 mice in either the 
cerebellum (CB, n=3 for each; p=0.89), cortex (CTX, n=6 for each; p=0.48), hippocampus (HC, n=6 for each; p=0.93), 
or midbrain (MB, n=6 for each; p=0.15). (C) The majority of TDP-43 aggregates in both sets of mice were found in the 
cytoplasm (HRE-10:n=6, HRE-102:n=5; p=0.87) with a minority in the nucleus (HRE-10: n=6, HRE-102: n=5; p=0.52). 
An unpaired two-tailed Student's t-test was used to assess data between the two mouse groups for all comparisons. 
Scale bar for (A): 10µm.  
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Fig S4. HRE-102 mice show age-related deficits in gait and activity compared to HRE-10 mice. (A-C) Progressive 
changes in HRE-102 mice in several gait phenotypes such as the front and hind stand index, front and hind swing
speed, and front and hind swing are not observed in HRE-10 mice (HRE-10:n=11, HRE-102:n=13; front stand index:
[F(1,42)=17.87, ***p=0.0001, post-hoc Sidek: HRE-10 (p=0.29), HRE-102 (p<0.0001)], hind stand index:[F(1,42)=18.63,
 ****p<0.0001, post-hoc Sidek:HRE-10 (p=0.17), HRE-102 (p=0.0001)], front swing speed:[F(1,42)=10.93, **p=0.002, 
post-hoc Sidek:HRE-10 (p=0.22), HRE-102 (p=0.007)], hind swing speed:[F(1,42)=9.27, **p=0.004, post-hoc Sidek: 
HRE-10 (p=0.49), HRE-102 (p=0.004)], front swing:[F(1,42)=15.96, ***p=0.0003, post-hoc Sidek:HRE-10 (p=0.15), 
HRE-102 (p=0.0007)], hind swing:[F(1,42)=14.46, ***p=0.0005, post-hoc Sidek:HRE-10 (p=0.42), HRE-102 
(p=0.0002)]. (D) HRE-102 mice were increasingly hypoactive with age in the open field in contrast to HRE-10 mice 
(HRE-10:n=10, HRE-102:n=13; front stand index:[F(1,42)=9.69, **p=0.003, post-hoc Sidek: HRE-10 (p=0.36), 
HRE-102 (p=0.005)]. (E) There were no differences on the accelerating rotarod between HRE-10 and HRE-102 mice 
[F(22,484)=0.84, p=0.67]; Two-way ANOVA, genotype x age interaction, all data presented as mean ± SEM.
Disease Models & Mechanisms 10: doi:10.1242/dmm.029892: Supplementary information
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
